Our studies demonstrate that curcumin can be used to overcome RA resistance in mammary carcinoma cells since curcumin suppresses FABP5 expression level, reducing the delivery of RA to PPARβ/δ and downregulating the expression of PPARβ/δ target gene. This evidence concerns the gene PPARD and breast carcinoma.